drugset / Trial / NCT01040455

Lansoprazole for Subgroups of Functional Dyspepsia

NCT01040455

Phase 4 Terminated 30 enrolled National Taiwan University Hospital Takeda · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Pharmacotherapy for functional dyspepsia remains unsatisfactory. Previous randomized trials reported conflicting results on clinical effectiveness of proton pump inhibitor in patients with functional dyspepsia. This study aims to examine whether lansoprazole 15mg is more effective than placebo for functional dyspepsia in Taiwanese patients, and to investigate the association between subgroups of patients and therapeutic response.

Timeline

Start
2009-12
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 15 mg

Indications